polymerase chain reaction detection of bacterial 16s rrna gene in human blood

8
Microbiol Immunol 2008; 52: 375–382 doi:10.1111/j.1348-0421.2008.00048.x NOTE Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood Kosei Moriyama 1 , Chie Ando 2 , Kosuke Tashiro 3 , Satoru Kuhara 3,4 , Seiichi Okamura 5 , Shuji Nakano 1 , Yasumitsu Takagi 6 , Takeyoshi Miki 6 , Yoshiyuki Nakashima 2 and Hideki Hirakawa 4 1 Nakamura Gakuen University, Faculty of Nutritional Sciences, 2 Department of Medicine and 6 Frontier Research Center, Fukuoka Dental College, 3 Graduate School of Genetic Resources Technology and 4 Graduate School of Systems Life Sciences, Kyushu University and 5 Department of Medicine, National Kyushu Medical Center, Fukuoka, Japan ABSTRACT Bacterial 16S ribosomal RNA genes (rDNA) were detected in blood samples from two healthy individuals by PCR under conditions involving 30 cycles that did not produce any visible products from negative control saline. Even from control samples, PCR involving 35–40 cycles yielded visible bands. Major clones detected in the blood samples, but not in control, were the Aquabacterium subgroup, Stenotrophomonas subgroup, Budvicia subgroup, Serratia subgroup, Bacillus subgroup and Flavobacteria subgroup. No clone was located within the bacteroides-clostridium-lactobacillus cluster, which is indigenous to gas- trointestinal flora. Key words bacteremia, blood, polymerase chain reaction, 16S ribosomal RNA. Diagnosis of bacterial infection and identification of the agent responsible is essential in clinical medicine, and has been traditionally carried out by inoculating blood or in- fected tissues into a liquid or solid nutrient medium. This approach has a limitation in that it can detect only bacte- ria and fungi that are culturable in a laboratory. Recently, PCR using species-specific primers (1–5) and nucleic acid sequence-based amplification (NASBA) (6) have also been used as an alternative approach for detecting agents that are responsible for infection. These techniques can also be used for detailed analysis of microbial biota in the oral cavity and gastrointestinal tract, using universal primers that anneal to conserved regions in the 16S ribosomal RNA gene (rDNA) or gyr B gene (7–9). It is reported that half of the bacteria comprising the oral and intestinal flora have not been previously identified by in vitro culture procedures (10). Moreover, recent studies using PCR have raised the possibility that bacterial DNA may be present in the human bloodstream (11–13). Correspondence Yoshiyuki Nakashima, Department of Medicine, Fukuoka Dental College, Tamura 2–15-1, Sawara-ku, Fukuoka 814-0193, Japan. Tel: +81 92 801 0411; fax: +81 92 865 2484; email: [email protected] Received 29 August 2007; revised 26 March 2008; accepted 17 April 2008 List of Abbreviations: EDTA, ethylenediaminetetraacetic acid; PCR, polymerase chain reaction. Our ultimate objective is to elucidate the role of such subclinically infecting unculturable or latent bacteria in the pathogenesis of chronic vascular diseases (14–16). As a first step, we investigated whether bacteria can translocate in some way from the oral and intestinal flora to the blood stream in ‘healthy’ humans. In this preliminary study, blood specimen-specific bacterial sequences were detected by PCR of rDNA. However, they were not representative of sequences found in human intestine. PCR was done with a REDExtract-N-Amp Blood PCR kit (Sigma-Aldrich Japan, Tokyo, Japan) using broad- range 16S ribosomal RNA gene (rDNA)-specific oligonu- cleotide primers. The PCR kit does not require any type of purification, organic extraction, centrifugation or alcohol precipitation, and can be used with whole blood. For blood sampling, the skin was first sterilized with a cotton swab moistened with popidone iodide, the an- terior brachial median vein was punctured using a ster- ile 21-gauge needle (Terumo Corporation, Tokyo, Japan), c 2008 The Societies and Blackwell Publishing Asia Pty Ltd 375

Upload: kosei-moriyama

Post on 14-Jul-2016

214 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

Microbiol Immunol 2008; 52: 375–382doi:10.1111/j.1348-0421.2008.00048.x

NOTE

Polymerase chain reaction detection of bacterial 16S rRNAgene in human bloodKosei Moriyama1, Chie Ando2, Kosuke Tashiro3, Satoru Kuhara3,4, Seiichi Okamura5, Shuji Nakano1,Yasumitsu Takagi6, Takeyoshi Miki6, Yoshiyuki Nakashima2 and Hideki Hirakawa4

1Nakamura Gakuen University, Faculty of Nutritional Sciences, 2Department of Medicine and 6Frontier Research Center, Fukuoka Dental College,3Graduate School of Genetic Resources Technology and 4Graduate School of Systems Life Sciences, Kyushu University and 5Department of Medicine,National Kyushu Medical Center, Fukuoka, Japan

ABSTRACTBacterial 16S ribosomal RNA genes (rDNA) were detected in blood samples from two healthy individualsby PCR under conditions involving 30 cycles that did not produce any visible products from negativecontrol saline. Even from control samples, PCR involving 35–40 cycles yielded visible bands. Major clonesdetected in the blood samples, but not in control, were the Aquabacterium subgroup, Stenotrophomonassubgroup, Budvicia subgroup, Serratia subgroup, Bacillus subgroup and Flavobacteria subgroup. Noclone was located within the bacteroides-clostridium-lactobacillus cluster, which is indigenous to gas-trointestinal flora.

Key words bacteremia, blood, polymerase chain reaction, 16S ribosomal RNA.

Diagnosis of bacterial infection and identification of theagent responsible is essential in clinical medicine, and hasbeen traditionally carried out by inoculating blood or in-fected tissues into a liquid or solid nutrient medium. Thisapproach has a limitation in that it can detect only bacte-ria and fungi that are culturable in a laboratory. Recently,PCR using species-specific primers (1–5) and nucleic acidsequence-based amplification (NASBA) (6) have also beenused as an alternative approach for detecting agents thatare responsible for infection.

These techniques can also be used for detailed analysis ofmicrobial biota in the oral cavity and gastrointestinal tract,using universal primers that anneal to conserved regions inthe 16S ribosomal RNA gene (rDNA) or gyr B gene (7–9).It is reported that half of the bacteria comprising the oraland intestinal flora have not been previously identified byin vitro culture procedures (10). Moreover, recent studiesusing PCR have raised the possibility that bacterial DNAmay be present in the human bloodstream (11–13).

CorrespondenceYoshiyuki Nakashima, Department of Medicine, Fukuoka Dental College, Tamura 2–15-1, Sawara-ku, Fukuoka 814-0193, Japan.Tel: +81 92 801 0411; fax: +81 92 865 2484; email: [email protected]

Received 29 August 2007; revised 26 March 2008; accepted 17 April 2008

List of Abbreviations: EDTA, ethylenediaminetetraacetic acid; PCR, polymerase chain reaction.

Our ultimate objective is to elucidate the role of suchsubclinically infecting unculturable or latent bacteria inthe pathogenesis of chronic vascular diseases (14–16). As afirst step, we investigated whether bacteria can translocatein some way from the oral and intestinal flora to the bloodstream in ‘healthy’ humans. In this preliminary study,blood specimen-specific bacterial sequences were detectedby PCR of rDNA. However, they were not representativeof sequences found in human intestine.

PCR was done with a REDExtract-N-Amp Blood PCRkit (Sigma-Aldrich Japan, Tokyo, Japan) using broad-range 16S ribosomal RNA gene (rDNA)-specific oligonu-cleotide primers. The PCR kit does not require any type ofpurification, organic extraction, centrifugation or alcoholprecipitation, and can be used with whole blood.

For blood sampling, the skin was first sterilized witha cotton swab moistened with popidone iodide, the an-terior brachial median vein was punctured using a ster-ile 21-gauge needle (Terumo Corporation, Tokyo, Japan),

c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd 375

Page 2: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

K. Moriyama et al.

and the blood was aspirated into an attached sterile glasstube under vacuum containing EDTA. For control sam-ples, the skin was sterilized as described above, and wipedwith an autoclaved (121 ◦C, 20 min, three times) cottonswab moistened with autoclaved saline. The saline in theswab was then squeezed directly into the EDTA-containingtube, and used as a negative control for PCR. Appendedneutralized dilution buffer with autoclaved saline was usedas another negative control.

This study was conducted in accordance with the rulesof the internal review board and the tenets of the Dec-laration of Helsinki. The Ethics Committee of FukuokaDental College, where blood sampling and laboratory ma-nipulations were carried out, approved the study, andboth of the study subjects gave informed consent toparticipate.

The forward primer was JRP-1: 5′ CTCCTACGGGAG-GCAGCAG and the reverse primer JRP-3: 5′ ACATGCTC-CACCGCTTGTG. The PCR primers were designed fromthe conserved regions of rRNA sequences of oral and in-testinal bacteria deposited in GenBank. At the presenttime, JRP-1 is completely (100%) identical to 339 766 of471 792 sequences deposited in the Ribosomal DatabaseProject II (17). Also, JRP-3 is completely identical to131 594 of 471 792 deposited sequences. Taking into ac-count one- or two-base mismatch annealing in PCR, thisprimer pair is capable of amplifying more than half of thedeposited sequences including Bacteroides and Clostrid-ium subgroups.

Either fresh whole blood or saline (10 μL; negativecontrol) was mixed with 20 μL lysis buffer, and further di-luted with 180 μL neutralization buffer. Neutralized sam-ple (2 μL) was added to 18 μL PCR mixture, and 30(or more as indicated in Results) cycles of PCR were car-ried out using TaKaRa PCR Thermal Cycler PERSONAL(TaKaRa Inc., Shiga, Japan). One cycle consisted of 1 minat 94 ◦C for denaturation, 30 s at 58 ◦C for annealing and40 s at 72 ◦C for extension. Amplicons were resolved byagarose gel electrophoresis and detected by ethidium bro-mide staining.

DNA (600–650 bp) was excised from the gel, and clonedinto the pGEM-T vector (Promega KK, Tokyo, Japan). Es-cherichia coli JM109 was transformed with the plasmidconstructs, and plated on Luria broth (LB) agar. For eachsubject, 96 white colonies were randomly detected, cul-tured in 1.5 mL LB broth, and the plasmids were extracted.The plasmids were digested with restriction enzymes PstIand EcoRI, electrophoresed in agarose gel, and the plas-mids carrying an approximately 620-bp fragment weresequenced.

Nucleotide sequence analysis was carried out usingan ABI automated DNA sequencer (model 373A) andan ABI Prism cycle sequencing kit (Perkin-Elmer Japan,

Tokyo, Japan). To confirm that the nucleotide sequenceswere 16S rDNA, homologous searches were performedagainst the non-redundant (nr) protein database in theNational Center for Biotechnology Information (NCBI)(http://www.ncbi.nlm.nih.gov/) using BLASTX (18). Se-quences that were not homologous with any proteinswere searched against 471 792 clones of 16S rDNA se-quences deposited in the Ribosomal Database Project II(RDP) (http://rdp.cme.msu.edu/) (17). For each rDNAsequence, the nearest genus and species of the type strainwas searched in the RDP, and best-hit names and se-quences were retrieved and shown as a phylogenetic tree.The alignment of the 16S rDNA sequences and the sam-pled sequences was performed using CLUSTAL W (19), andthe unrooted neighbor-joining tree was constructed usingNJPLOT (20). In phylogenic analysis, the distance betweentwo given sequences was expressed as the number of dif-ferences per 100 bases. Bacterial groups with a distanceof more than 0.02 (i.e. 12 mutations in 600 bases) weredefined as different.

To test whether rDNA of oral and intestinal bacteriais detectable in human blood, we designed PCR primersto amplify 16S ribosomal RNA genes. The amounts ofPCR products in blood samples from two healthy indi-viduals were higher than those in control samples. Using30 thermal cycles, all PCR products from blood samplesgave bands of the expected size (approximately 620 bp) byagarose gel electrophoresis and ethidium bromide stain-ing, whereas those from the negative control gave novisible bands (Fig. 1). Attempts were made to amplifyany rDNA in the negative control samples, and it was

Fig. 1. Agarose gel electrophoresis and ethidium bromide staining ofPCR products. (a) Products of 30-cycle reaction. A, whole blood of subjectA; B, whole blood of subject B; S1, saline in cotton swab used to wipethe skin of subject A; S2, saline in cotton swab used to wipe the skinof subject B. (b) Products of 40-cycle reaction. S1, saline in cotton swabused to wipe the skin of subject A; S2, saline in cotton swab used towipe the skin of subject B; C, PCR with neutralized dilution buffer withautoclaved saline.

376 c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd

Page 3: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

Bacterial rRNA gene in human blood

Table 1 PCR cycles and numbers of clones sequenced

No. colonies detected No. extracted plasmids carrying a 600–650 bpPCR cycle for small scale culture fragment for nucleotide sequence analysis No. clones identified as bacterial rRNA genes

Subject A 30 96 24 23Subject B 30 96 31 31Control† 40 96 96 86

†Control PCR (40-cycle) with intensively autoclaved saline (C in Fig. 1b).

found that 35 to 40 cycles yielded visible bands with sev-eral extra bands and smears by agarose gel electrophore-sis; amplicons obtained by 40-cycle PCR are shown inFigure 1b.

The 30-cycle PCR products from subjects A and B (Aand B in Fig. 1a), and 40-cycle PCR products from controlsaline (C in Fig. 1b) were further analyzed. The numbers ofbacterial 16S rDNAs analyzed were 23 clones from subjectA, 31 clones from subject B, and 86 clones from controlsaline (Table 1) (Appendix I).

As shown in the phylogenetic tree, members of variousbacterial groups were detected in the blood specimen-associated clone libraries (Fig. 2). Among the controlreagent-associated sequences, various subgroups in α-,β- and γ-proteobacteria were identified. Clone sequencesthat were detected in either of two human blood sam-ples, but not in the control sample, were the Aquabac-terium subgroup, Stenotrophomonas subgroup, Budvi-cia subgroup, Serratia subgroup, Bacillus subgroup andFlavobacterium subgroup. None of these sequences wasclassified as the same group as the representative sequencesfound in human intestine by Hayashi et al. (10).

PCR using 30 thermal cycles yielded positive bandsby agarose gel electrophoresis from all blood samples,whereas negative controls yielded no visible bands. How-ever, 35 to 40 cycles of PCR for the negative control salinesample gave visible rDNA bands. We used a PCR kit thatworks with raw blood specimens and requires no ma-nipulation for DNA extraction. However, rDNA can beintroduced at any stage of processing during the manu-facture of PCR enzymes and buffers, or by experimen-tal manipulations such as pipeting and opening of testtubes. The majority of the rDNA sequences in the librariesfrom the negative control samples were similar to thoseof Acinetobacter haemolyticus, Variovorax parodoxus andPseudomonas fluorescens, which are all common water-and soil-associated organisms, and have been reportedto be major contaminants of Taq polymerase and otherreagents for PCR (21–25).

Venipuncture provides an opportunity for introducingexogenous bacterial genomes into the bloodstream frombacteria resident on the skin surface. The outer diameter ofa 21-gauge needle is 0.80 mm, and therefore the punctured

area of skin is calculated to be 5 × 105 μm2. As thediameter of a bacterium is approximately 2 μm, roughly1 × 105 bacteria can theoretically adhere as a monolayerwithin this area.

Another explanation for the positive results obtainedfrom blood samples with 30 PCR cycles is that the bloodof healthy individuals contains a bacterial component.Based on the number of thermal cycles (35 cycles minus30 cycles), the copy number of rDNA in blood samples isthought to be approximately 25-fold higher than that incontrol saline.

A positive result in any PCR tube means that the tubecontains at least one copy of rDNA. Therefore, 10 μL ofstarting material (raw blood) contains at least one copy ofrDNA (100 copy/mL). Given that one bacterial cell pos-sesses 10 duplicated rDNA genes, PCR-positive blood has10 bacterial cells per 1 mL. As the one PCR used 2 μLof 105-fold diluted blood, the actual number of bacteriawould be greater. With such a degree of bacteremia, any an-imal would be critically ill. Therefore, if healthy individualsharbor a bacterial component in their blood, the rDNAmust originate from destroyed (i.e. non-viable) bacteria.Bacteria may be destroyed by physical and immunologicalbarriers, and the released rDNA may be translocated intothe bloodstream. This bacterial rDNA would be presentfreely in plasma and/or trapped in granulocytes.

The rDNA sequences found in the blood specimenswere those of Stenotrophomonas, Budvicia, Serratia, Bacil-lus, Flavobacterium and Aquabacterium subgroups. Theblood-associated rDNA sequences were not assigned toany of the major bacterial phylotypes indigenous to theperiodontal flora (7, 26–28). Furthermore, there was norDNA sequence identical to those of bacterial families in-digenous to the jejunal and ileal flora or fecal flora detectedby Hayashi et al. (10), such as Streptococcus, Lactobacil-lus, Enterococcus, Bacteroides and Clostridium subgroups(Fig. 2).

By whole-genome shotgun sequencing, Kurokawa et al.(29) reported that Bacteroides and Clostridium are ma-jor subgroups comprising the fecal flora of adult hu-mans. These taxonomic names were not found in ourblood specimen-associated subgroups. Only the Bacillussubgroup, the third population in the gut in Kurokawa’s

c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd 377

Page 4: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

K. Moriyama et al.

NR_003286; Homo sapiens 18S rDNA A-3-2 S01_E02 S01_F11 S01_G09 S01_B02 A-1-4_A07 S01_H07 S01_H09 S01_F08 S01_E07 S01_C12 S01_H10 S01_D02 S01_G12 S01_B10 S01_G03 S01_C10 S01_B05 S000435815; Variovorax paradoxus IAM 12373 [β-Proteobacteria] S000619996; Variovorax paradoxus 4.2 [β-Proteobacteria] S000627894; Variovorax ginsengisoli Gsoil 3165 [β-Proteobacteria] S01_D08 S000332064; Rhodoferax antarcticus Fryx1 [β-Proteobacteria] S000804271; Acidovorax delafieldii HYY0511-SK09 [β-Proteobacteria] S01_H05 S000805102; Acidovorax avenae subsp. avenae [β-Proteobacteria] S01_A10 S01_C05 S000015591; Curvibacter lanceolatus ATCC 14669T (T) [β-Proteobacteria] S01_G08 S000428512; Curvibacter delicatus LMG 4328 (T) [β-Proteobacteria] A-1-14_G09 S000629316; Comamonas testosteroni DSM 6781 [β-Proteobacteria] S000387156; Hydrogenophaga palleronii DSM 63 (T) [β-Proteobacteria] S01_C08 S01_C07 S01_F03 A-1-9_E09 S000427920; Aquabacterium parvum B6 (T) [β-Proteobacteria] A-3-4 S000427918; Aquabacterium citratiphilum B4 (T) [β-Proteobacteria] N-2-37_H12 A-1-19_H09 A-1-1_B09 S000008887; Janthinobacterium agaricidamnosum W1r3T (T) [β-Proteobacteria] S000125062; Antarctic bacterium R-7614 S000805623; Janthinobacterium lividum H196 [β-Proteobacteria] A-3-1 A-3-10 N-1-15_D12 N-3-9 S01_A05 S01_G07 S01_E03 S01_F07 S01_D06 S01_C11 A-1-7_C09 A-3-6 A-1-8_D09 A-3-5 S000438965; Janthinobacterium agaricidamnosum SAFR-022 [β-Proteobacteria] N-1-23_G07 N-3-11 N-2-35_F12 S000824200; Herminiimonas oxalatica NS11 (T) [β-Proteobacteria] S01_A06 S01_E09 S01_B03 S01_H01 S01_G05 S000425945; Burkholderia cepacia ATCC 55487 [β-Proteobacteria] S01_E12 S01_C06 A-1-9_B07 S000824097; Stenotrophomonas maltophilia NCB0306-284 [γ-Proteobacteria] A-3-12 A-3-3 A-3-7 N-2-47_A09 N-3-6 N-3-12 S000769255; Xanthomonas axonopodis IP1-36 [γ-Proteobacteria] S01_A01 S01_G10 S01_C04 S01_H04 A-2-25_E07 A-3-11 A-3-9 S000776605; Acinetobacter junii 2R11 [γ-Proteobacteria] S01_C03 S01_F05 N-2-31_E12 N-1-1_B12 S01_E04 S01_D09 S01_F02 S01_B04 S01_H06 S01_A09 S01_H03 S01_F01 S01_B11 S01_D12 S01_G01 S01_H12 S01_B08 S01_D04 S01_A03 S01_A08 S01_B01 S01_F12 S01_B12 N-1-15_F07 N-3-1 S01_B07 S01_D05 S01_E10 N-3-10 S000434893; Acinetobacter haemolyticus AY047216 [γ-Proteobacteria] N-2-42_G08 N-3-7 S01_G02 S000559117; Pseudomonas fluorescens S16 [γ-Proteobacteria] S01_E08 S01_D10 S01_E01 S01_E11 S000824936; Pseudomonas fluorescens 29L [γ-Proteobacteria] N-3-4 N-2-38_F08 S000020702; Budvicia aquatica DSM 5075 (T) [γ-Proteobacteria] N-2-26_A08 N-3-3 N-2-34_E08 S000736666; Serratia grimesii DQ991163 [γ-Proteobacteria] N-1-2_C12 N-3-2 N-2-33_D08 N-3-8 S000381739; Enterobacter asburiae JCM6051 (T) [γ-Proteobacteria] S000436668; Aggregatibacter actinomycetemcomitans (T) [γ-Proteobacteria] S000391702; Aminobacter aminovorans Ep2-1c [α-Proteobacteria] N-2-45_H08 N-2-28_B08 N-3-5 S01_H02 S000721041; Rhizobium radiobacter MAFF 03-01224 [α-Proteobacteria] S01_F04 S000825175; Rhizobium leguminosarum BIHB 1157 [α-Proteobacteria] S01_G11 S000805621; Brevundimonas nasdae G124 [α-Proteobacteria] S01_D01 S01_H08 S01_A11 S01_D03 S000824151; Caulobacter vibrioides CB15 [α-Proteobacteria] S01_F06 S01_A07 S01_C01 A-1-21_C07 S000825335; Bacillus cereus [Firmicutes] N-2-25_H07 A-3-8 A-1-23_D07 S000375664; Enterococcus faecalis SL5 [Firmicutes] S000389017; Sporosarcina ureae DSM 2281 (T) [Firmicutes] S000128223; Streptococcus salivarius NCDO 1779 (T) [Firmicutes] S000134021; Streptococcus mutans NCTC 10449 (T) [Firmicutes] S000436427; Lactococcus lactis cremoris (T) [Firmicutes] S000414529; Lactobacillus reuteri (T) [Firmicutes] S000414606; Eubacterium cylindroides ATCC 27803 (T) [Fir micutes] S000001177; Ruminococcus gnavus ATCC 29149 (T) [Firmicutes] S000012710; Clostridium xylanolyticum ATCC 4963 (T) [Fir micutes] S000414600; Eubacterium ventriosum (T) [Firmicutes] S000436477; Ruminococcus hansenii (T) [Firmicutes] S000011936; Clostridium polysaccharolyticum DSM 1801 (T) [Firmicutes] S000437588; Butyrivibrio fibrisolvens ATCC 19171 (T) [Firmicutes] S000414263; Peptostreptococcus anaerobius ATCC 27337 (T) [Fir micutes] S000013701; Phascolarctobacterium faecium (T) [Firmicutes] S01_C02 S01_D07 N-2-29_C08 S000381050; Bifidobacterium bifidum (T) [Actinobacteria] S000484536; Rothia amarae J18 (T) [Actinobacteria] S000617880; Propionibacterium acnes mother C4 [Actinobacteria] S01_G06 S01_A12 S01_E06 S000390110; Ferrimicrobium acidiphilum T23 [Actinobacteria] S01_F09 S000006150; Desulfovibrio desulfuricans ATCC 29577 (T) [δ-Proteobacteria] S000010833; Malonomonas rubra GraMal1 (T) [δ-Proteobacteria] S000015699; Desulfuromusa kysingii Kysw2 (T) [δ-Proteobacteria] S000006649; Porphyromonas gingivalis DSM 20709 (T) [Bacteroidetes] S000414478; Tannerella forsythensis 338 (T) [Bacteroidetes] S000528932; Bacteroides fragilis NCTC 9343 [Bacteroidetes] S000135891; Flavobacteria symbiont 1 of Acromyrmex otcospinosus [Bacteroidetes] N-2-36_G12 S000436460; Clostridium leptum (T) [Firmicutes]

0.000.040.080.120.160.200.240.280.32

Fig. 2. Phylogenetic relationships inferred from bacterial 16S rDNA se-quences detected in blood specimens from two healthy individuals andfrom control clone library sequences. The sequences associated with theblood specimens (30-cycle PCR) are shown in blue (subject A) and red(subject B) (Fig. 1a), respectively, and those generated in a control (40-cycle) PCR (C in Fig. 1b) as a template are shown in green. Referencesequences showing closest similarity to the study sequences are indi-cated in black. Representative sequences found in human intestine byHayashi et al. (10) are indicated in brown. The distance between twogiven sequences was expressed as the number of differences per 100bases.

study, was included among our blood-associated taxo-nomic groups (Appendix II). Therefore, it is unlikely thatthe gastrointestinal tract, the largest reservoir of bacte-rial flora, is the main source of blood rDNA in ‘healthy’humans. If the rDNA (or bacteria) translocates from theintestinal lumen to the circulatory system, there must bestrong selective pressures for bacterial species.

The Stenotrophomonas, Budvicia, Serratia, Bacillus,Flavobacterium and Aquabacterium subgroups are soil-and water-associated bacteria. The former four sub-groups, Stenotrophomonas, Budvicia, Serratia and Bacil-lus, can be opportunistic pathogens. By using rDNA-specific PCR, Nikkari et al. have shown a possibilitythat the Stenotrophomonas, Bacillus and Riemerella sub-groups are blood sample specific (13). In our study, theStenotrophomonas and Bacillus subgroups were also de-tected as blood sample specific. This supports Nikkariet al.’s speculation that there might be a ‘normal’ popu-lation of bacterial DNA sequences in the circulatory sys-tem of ‘healthy’ humans (13). Another possibility is thatthese airborne soil bacteria are constantly aspirated, be-ing continuously destroyed in the surface mucosa of therespiratory system, and that the released rDNA may enterthe bloodstream directly or be carried by phagocytes. Thismay also explain why some of our blood-associated rDNAsequences differed from those found in studies reportedpreviously from geographically different laboratories (11–13).

ACKNOWLEDGMENT

We thank Professor Mutsuo Sekiguchi, Fukuoka DentalCollege, for pertinent advice. This work was supported bya grant-in-aid from the Ministry of Education, Science,Sports and Culture of Japan (Frontier Research Grant).

REFERENCES

1. Anthony R.M., Brown T.J., French G.L. (2000) Rapid diagnosis ofbacteremia by universal amplification of 23S ribosomal DNAfollowed by hybridization to an oligonucleotide array. J ClinMicrobiol 38: 781–8.

2. Cursons R.T., Jeyerajah E., Sleigh J.W. (1999) The use of polymerasechain reaction to detect septicemia in critically ill patients. Crit CareMed 27: 937–40.

3. Kotilainen P., Jalava J., Meurman O., Lehtonen O.P., Rintala E.,Seppala O.P. et al. (1998) Diagnosis of meningococcal meningitis bybroad-range bacterial PCR with cerebrospinal fluid. J ClinMicrobiol 36: 2205–9.

4. Ley B.E., Linton C.J., Bennett D.M., Jalal H., Foot A.B., Millar M.R.(1998) Detection of bacteraemia in patients with fever andneutropenia using 16S rRNA gene amplification by polymerasechain reaction. Eur J Clin Microbiol Infect Dis 17: 247–53.

5. Rantakokko-Jalava K., Nikkari S., Jalava J., Eerola E., Skurnik M.,Meurman O. et al. (2000) Direct amplification of rRNA genes indiagnosis of bacterial infections. J Clin Microbiol 38: 32–9.

378 c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd

Page 5: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

Bacterial rRNA gene in human blood

6. van der Vliet G.M., Schukkink R.A., van Gemen B., Schepers P.,Klatser P.R. (1993) Nucleic acid sequence-based amplification(NASBA) for the identification of mycobacteria. J Gen Microbiol139: 2423–9.

7. Kroes I., Lepp P.W., Relman D.A. (1999) Bacterial diversity withinthe human subgingival crevice. Proc Natl Acad Sci USA 96:14 547–52.

8. Nakanishi S., Kataoka K., Kuwahara T., Ohnishi Y. (2003) Effects ofhigh amylose maize starch and Clostridium butyricum onmetabolism in colonic microbiota and formation ofazoxymethane-induced aberrant crypt foci in the rat colon.Microbiol Immunol 47: 951–8.

9. Zucol F., Ammann R.A., Berger C., Aebi C., Altwegg M., Niggli F.K.et al. (2006) Real-time quantitative broad-range PCR assay fordetection of the 16S rRNA gene followed by sequencing for speciesidentification. J Clin Microbiol 44: 2750–9.

10. Hayashi H., Takahashi R., Nishi T., Sakamoto M., Benno Y. (2005)Molecular analysis of jejunal, ileal, caecal and recto-sigmoidalhuman colonic microbiota using 16S rRNA gene libraries andterminal restriction fragment length polymorphism. J MedMicrobiol 54: 1093–101.

11. Brecher M.E., Hay S.N. (2005) Bacterial contamination of bloodcomponents. Clin Microbiol Rev 18: 195–204.

12. McLaughlin R.W., Vali H., Lau P.C.K., Palfree R.G.E., De Ciccio A.,Sirois M. et al. (2002) Are there naturally occurring pleomorphicbacteria in the blood of healthy humans? J Clin Microbiol 40:4771–5.

13. Nikkari S., McLaughlin I.J., Bi W., Dodge D.E., Relman D.A. (2001)Does blood of healthy subjects contain bacterial ribosomal DNA? JClin Microbiol 39: 1956–9.

14. Loesche W.J. (1997) Association of the oral flora with importantmedical diseases. Curr Opin Periodontol 4: 21–8.

15. Ohsuzu F. (2004) The roles of cytokines, inflammation andimmunity in vascular diseases. J Atheroscler Thromb 11: 313–21.

16. Stoll L.L., Denning G.M., Weintraub N.L. (2004) Potential role ofendotoxin as a proinflammatory mediator of atherosclerosis.Arterioscler Thromb Vasc Biol 24: 2227–36.

17. Cole J.R., Chai B., Farris R.J., Wang Q., Kulam-Syed-MohideenA.S., McGarrell D.M. et al. (2007) The ribosomal database project(RDP-II): introducing myRDP space and quality controlled publicdata. Nucleic Acids Res 35: D169–72.

18. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., MillerW. et al. (1997) Gapped BLAST and PSI-BLAST: a new generationof protein database search programs. Nucleic Acids Res 25:3389–402.

19. Thompson J.D., Higgins D.G., Gibson T.J. (1994) CLUSTALW:improving the sensitivity of progressive multiple sequencealignment through sequence weighting, position-specific gappenalties and weight matrix choice. Nucleic Acids Res 22: 4673–80.

20. Perriere G., Gouy M. (1996) WWW-Query: An on-line retrievalsystem for biological sequence banks. Biochimie 78: 364–9.

21. Cho J.C., Kim S.J. (2000) Increase in bacterial community diversityin subsurface aquifers receiving livestock wastewater input. ApplEnviron Microbiol 66: 956–65.

22. Corless C.E., Guiver M., Borrow R., Edwards-Jones V., KaczmarskiE.B., Fox A.J. (2000) Contamination and sensitivity issues with areal-time universal 16S rRNA PCR. J Clin Microbiol 38: 1747–52.

23. Hughes M.S., Beck L.A., Skuce R.A. (1994) Identification andelimination of DNA sequences in Taq DNA polymerase. J ClinMicrobiol 32: 2007–8.

24. Rand K.H., Houck H. (1990) Taq polymerase contains bacterialDNA of unknown origin. Mol Cell Probes 4: 445–50.

25. Tanner M.A., Goebel B.M., Dojka M.A., Pace N.R. (1998) Specificribosomal DNA sequences from diverse environmental settingscorrelate with experimental contaminants. Appl Environ Microbiol64: 3110–13.

26. Kumar P.S., Griffen A.L., Moeschberger M.L., Leys E.J. (2005)Identification of candidate periodontal pathogens and beneficialspecies by quantitative 16S clonal analysis. J Clin Microbiol 43:3944–55.

27. Paster B.J., Boches S.K., Galvin J.L., Ericson R.E., Lau C.N., LevanosV.A. et al. (2001) Bacterial diversity in human subgingival plaque. JBacteriol 183: 3770–83.

28. Sakamoto M., Umeda M., Ishikawa I., Benno Y. (2000) Comparisonof the oral bacterial flora in saliva from a healthy subject and twoperiodontitis patients by sequence analysis of 16S rDNA libraries.Microbiol Immunol 44: 643–52.

29. Kurokawa K., Itoh T., Kuwahara T., Oshima K., Toh H., Toyoda A.et al. (2007) Comparative metagenomics revealed commonlyenriched gene sets in human gut microbiomes. DNA Res 14:169–81.

APPENDIX I

DDBJ accession numbers

All new rDNA sequences described in the presentstudy have been registered in the DNA Data Bank ofJapan (DDBJ) as numbers AB331781 ∼ AB331834 andAB374430 ∼ AB374515.

(Control sample)

S01 A01 AB374430S01 A03 AB374431S01 A05 AB374432S01 A06 AB374433S01 A07 AB374434S01 A08 AB374435S01 A09 AB374436S01 A10 AB374437S01 A11 AB374438S01 A12 AB374439S01 B01 AB374440S01 B02 AB374441S01 B03 AB374442S01 B04 AB374443S01 B05 AB374444S01 B07 AB374445S01 B08 AB374446S01 B10 AB374447S01 B11 AB374448S01 B12 AB374449S01 C01 AB374450S01 C02 AB374451S01 C03 AB374452S01 C04 AB374453S01 C05 AB374454S01 C06 AB374455S01 C07 AB374456

c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd 379

Page 6: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

K. Moriyama et al.

Continued.

(Control sample)

S01 C08 AB374457S01 C10 AB374458S01 C11 AB374459S01 C12 AB374460S01 D01 AB374461S01 D02 AB374462S01 D03 AB374463S01 D04 AB374464S01 D05 AB374465S01 D06 AB374466S01 D07 AB374467S01 D08 AB374468S01 D09 AB374469S01 D10 AB374470S01 D12 AB374471S01 E01 AB374472S01 E02 AB374473S01 E03 AB374474S01 E04 AB374475S01 E06 AB374476S01 E07 AB374477S01 E08 AB374478S01 E09 AB374479S01 E10 AB374480S01 E11 AB374481S01 E12 AB374482S01 F01 AB374483S01 F02 AB374484S01 F03 AB374485S01 F04 AB374486S01 F05 AB374487S01 F06 AB374488S01 F07 AB374489S01 F08 AB374490S01 F09 AB374491S01 F11 AB374492S01 F12 AB374493S01 G01 AB374494S01 G02 AB374495S01 G03 AB374496

Continued.

(Control sample)

S01 G05 AB374497S01 G06 AB374498S01 G07 AB374499S01 G08 AB374500S01 G09 AB374501S01 G10 AB374502S01 G11 AB374503S01 G12 AB374504S01 H01 AB374505S01 H02 AB374506S01 H03 AB374507S01 H04 AB374508S01 H05 AB374509S01 H06 AB374510S01 H07 AB374511S01 H08 AB374512S01 H09 AB374513S01 H10 AB374514S01 H12 AB374515

APPENDIX II

Referring to the metagenome dataof intestinal flora

Comparison of the blood sample-associated taxonomicnames in this study with the feces-associated taxonomicnames listed in Kurokawa’s metagenome analysis (29). Leftcolumn, bacterial sequences hit in our RDP search of bloodsample-associated sequences. Middle column, genus andspecies. Blood sample-specific taxonomic names (i.e. posi-tive in PCR of blood sample but negative in PCR of controlsaline sample) are indicated by underlines. The taxonomicnames identical to those listed in Kurokawa’s report are in-dicated in the right column. Kurokawa et al. reported thatBacteroides and Clostridium are major subgroups com-prising the fecal flora of adult humans. These taxonomicnames were not found in our blood specimen-associatedsubgroups. The Bacillus subgroup is the third populationin the gut in Kurokawa’s study.

380 c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd

Page 7: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

Bacterial rRNA gene in human blood

Sequ

ence

nam

eSp

ecie

sC

heck

inD

NA

rese

arch

S000

8051

02A

cido

vora

xav

enae

subs

pav

enae

EF09

1147

Aci

dovo

rax

aven

aeS0

0080

4271

Aci

dovo

rax

dela

field

iiH

YY

0511

-SK

09A

B269

774

Aci

dovo

rax

dela

field

iiS0

0043

4893

Aci

neto

bact

erha

emol

ytic

usA

Y04

7216

Aci

neto

bact

erha

emol

ytic

usS0

0077

6605

Aci

neto

bact

erju

nii

2R11

EF17

8436

Aci

neto

bact

erju

nii

S000

4366

68A

ggre

gatib

acte

rac

tinom

ycet

emco

mita

nsT

M75

039

Agg

rega

tibac

ter

actin

omyc

etem

com

itans

S000

3917

02A

min

obac

ter

amin

ovor

ans

Ep2–

1cA

F329

835

Am

inob

acte

ram

inov

oran

sS0

0012

5062

Ant

arct

icba

cter

ium

R-76

14A

J440

982

Ant

arct

icba

cter

ium

S000

4279

18A

quab

acte

rium

citr

atip

hilu

mT

B4A

F035

050

Aqu

abac

teriu

mci

trat

iphi

lum

S000

4279

20A

quab

acte

rium

parv

umT

B6A

F035

052

Aqu

abac

teriu

mpa

rvum

S000

8253

35Ba

cillu

sce

reus

EF46

8497

Baci

llus

cere

usLi

sted

byK

urok

awa

etal

.S0

0052

8932

Bact

eroi

des

frag

ilis

NC

TC93

43A

TCC

2528

5=

NC

TC93

43C

R626

927

Bact

eroi

des

frag

ilis

S000

3810

50Bi

fidob

acte

rium

bifid

umT

S836

24Bi

fidob

acte

rium

bifid

umS0

0080

5621

Brev

undi

mon

asna

sdae

G12

4EF

2042

09Br

evun

dim

onas

nasd

aeS0

0002

0702

Budv

icia

aqua

tica

TD

SM50

75A

J233

407

Budv

icia

aqua

tica

S000

4259

45Bu

rkho

lder

iace

paci

aA

TCC

5548

7A

Y74

1358

Burk

hold

eria

cepa

cia

S000

4375

88Bu

tyriv

ibrio

fibris

olve

nsT

ATC

C19

171

U41

172

Buty

rivib

riofib

risol

vens

S000

8241

51C

aulo

bact

ervi

brio

ides

CB1

5A

E005

673

Cau

loba

cter

vibr

ioid

esS0

0043

6460

Clo

strid

ium

lept

umT

M59

095

Clo

strid

ium

lept

umS0

0001

1936

Clo

strid

ium

poly

sacc

haro

lytic

umT

DSM

1801

X71

858

Clo

strid

ium

poly

sacc

haro

lytic

umS0

0001

2710

Clo

strid

ium

xyla

noly

ticum

TA

TCC

4963

X71

855

Clo

strid

ium

xyla

noly

ticum

S000

6293

16C

omam

onas

test

oste

roni

DSM

6781

AM

1137

45C

omam

onas

test

oste

roni

S000

4285

12C

urvi

bact

erde

licat

usT

LMG

4328

AF0

7875

6C

urvi

bact

erde

licat

usS0

0001

5591

Cur

viba

cter

lanc

eola

tus

TA

TCC

1466

9TA

B021

390

Cur

viba

cter

lanc

eola

tus

S000

0061

50D

esul

fovi

brio

desu

lfuric

ans

subs

pde

sulfu

rican

sT

Esse

x6

ATC

C29

577

AF1

9215

3D

esul

fovi

brio

desu

lfuric

ans

List

edby

Kur

okaw

aet

al.

S000

0156

99D

esul

furo

mus

aky

sing

iiT

Kys

w2

DSM

7343

X79

414

Des

ulfu

rom

usa

kysi

ngii

S000

3817

39En

tero

bact

eras

buria

eT

JCM

6051

AB0

0474

4En

tero

bact

eras

buria

eS0

0037

5664

Ente

roco

ccus

faec

alis

SL5

AY

6924

53En

tero

cocc

usfa

ecal

isS0

0041

4606

Euba

cter

ium

cylin

droi

des

TA

TCC

2780

3L3

4617

Euba

cter

ium

cylin

droi

des

S000

4146

00Eu

bact

eriu

mve

ntrio

sum

TL3

4421

Euba

cter

ium

vent

riosu

mS0

0039

0110

Ferr

imic

robi

umac

idip

hilu

mT2

3A

F251

436

Ferr

imic

robi

umac

idip

hilu

mS0

0013

5891

Flav

obac

teria

sym

bion

t1

ofA

crom

yrm

exot

cosp

inos

usA

F491

880

Flav

obac

teria

sym

bion

t

S000

8242

00H

erm

iniim

onas

oxal

atic

aty

pest

rain

NS1

1A

M49

3906

Her

min

iimon

asox

alat

ica

S000

3871

56H

ydro

geno

phag

apa

llero

nii

TD

SM63

AF0

1907

3H

ydro

geno

phag

apa

llero

nii

c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd 381

Page 8: Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood

K. Moriyama et al.

Con

tinue

d.

Sequ

ence

nam

eSp

ecie

sC

heck

inD

NA

rese

arch

S000

0088

87Ja

nthi

noba

cter

ium

agar

icid

amno

sum

TW

1r3T

Y08

845

Jant

hino

bact

eriu

mag

aric

idam

nosu

mS0

0043

8965

Jant

hino

bact

eriu

mag

aric

idam

nosu

mSA

FR-0

22A

Y16

7838

Jant

hino

bact

eriu

mag

aric

idam

nosu

mS0

0080

5623

Jant

hino

bact

eriu

mliv

idum

H19

6EF

2042

11Ja

nthi

noba

cter

ium

livid

umS0

0041

4529

Lact

obac

illus

reut

eri

TL2

3507

Lact

obac

illus

reut

eri

S000

4364

27La

ctoc

occu

sla

ctis

subs

pcr

emor

isT

M58

836

Lact

ococ

cus

lact

isS0

0001

0833

Mal

onom

onas

rubr

aT

Gra

Mal

1Y

1771

2M

alon

omon

asru

bra

S000

4142

63Pe

ptos

trep

toco

ccus

anae

robi

usT

ATC

C27

337

L041

68Pe

ptos

trep

toco

ccus

anae

robi

usS0

0001

3701

Phas

cola

rcto

bact

eriu

mfa

eciu

mT

X72

865

Phas

cola

rcto

bact

eriu

mfa

eciu

mS0

0000

6649

Porp

hyro

mon

asgi

ngiv

alis

TD

SM20

709

X73

964

Porp

hyro

mon

asgi

ngiv

alis

List

edby

Kur

okaw

aet

al.

S000

6178

80Pr

opio

niba

cter

ium

acne

sm

othe

rC

412

C4

AM

1574

38Pr

opio

niba

cter

ium

acne

sLi

sted

byK

urok

awa

etal

.

S000

5591

17Ps

eudo

mon

asflu

ores

cens

S16

DQ

0959

04Ps

eudo

mon

asflu

ores

cens

List

edby

Kur

okaw

aet

al.

S000

8249

36Ps

eudo

mon

asflu

ores

cens

29L

EF42

4136

Pseu

dom

onas

fluor

esce

nsLi

sted

byK

urok

awa

etal

.S0

0082

5175

Rhiz

obiu

mle

gum

inos

arum

BIH

B11

57EF

4372

20Rh

izob

ium

legu

min

osar

umS0

0072

1041

Rhiz

obiu

mra

diob

acte

rM

AFF

03–0

1224

AB2

4761

0Rh

izob

ium

radi

obac

ter

S000

3320

64Rh

odof

erax

anta

rctic

usFr

yx1

AY

6091

98Rh

odof

erax

anta

rctic

usS0

0048

4536

Roth

iaam

arae

TJ1

8A

S41

721

JCM

1137

5A

Y04

3359

Roth

iaam

arae

S000

0011

77Ru

min

ococ

cus

gnav

usT

ATC

C29

149

X94

967

Rum

inoc

occu

sgn

avus

S000

4364

77Ru

min

ococ

cus

hans

enii

TM

5911

4Ru

min

ococ

cus

hans

enii

S000

7366

66Se

rrat

iagr

imes

iiD

Q99

1163

Serr

atia

grim

esii

S000

3890

17Sp

oros

arci

naur

eae

DSM

2281

TA

F202

057

Spor

osar

cina

urea

eS0

0082

4097

Sten

otro

phom

onas

mal

toph

ilia

NC

B030

6–28

4A

B294

557

Sten

otro

phom

onas

mal

toph

ilia

S000

1340

21St

rept

ococ

cus

mut

ans

TN

CTC

1044

9T

X58

303

Stre

ptoc

occu

sm

utan

sLi

sted

byK

urok

awa

etal

.S0

0012

8223

Stre

ptoc

occu

ssa

livar

ius

NC

DO

1779

TX

5832

0St

rept

ococ

cus

saliv

ariu

sS0

0041

4478

Tann

erel

lafo

rsyt

hens

isT

338

L164

95Ta

nner

ella

fors

ythe

nsis

S000

6278

94Va

riovo

rax

gins

engi

soli

Gso

il31

65A

B245

358

Vario

vora

xgi

nsen

giso

liS0

0043

5815

Vario

vora

xpa

rado

xus

IAM

1237

3D

3079

3Va

riovo

rax

para

doxu

sS0

0061

9996

Vario

vora

xpa

rado

xus

42D

Q24

1396

Vario

vora

xpa

rado

xus

S000

7692

55X

anth

omon

asax

onop

odis

IP1–

36EF

1019

77X

anth

omon

asax

onop

odis

382 c© 2008 The Societies and Blackwell Publishing Asia Pty Ltd